第四批鼓励仿制药品目录发布

Group 1 - The article lists various pharmaceutical products along with their names, formulations, and types, indicating a focus on drug development and market offerings [2][3][4][5][6][7][8][9]. - Specific drugs mentioned include bexarotene, deflazacort, difelikefalin, eluxadoline, and others, highlighting a diverse range of therapeutic areas [2][4][5][7]. - The formulations include capsules, tablets, injectable forms, and gels, suggesting a comprehensive approach to drug delivery methods [2][3][4][5][6][7][8][9]. Group 2 - The document provides detailed information on the dosage forms and types of each drug, which is crucial for understanding their application in clinical settings [2][3][4][5][6][7][8][9]. - The presence of both oral and injectable formulations indicates a strategic focus on meeting various patient needs and preferences [2][4][5][7][8][9]. - The inclusion of specific dosage amounts and types, such as micrograms and milligrams, reflects the precision required in pharmaceutical development [2][4][5][6][7][8][9].